Williams Rosemary Y.

VP, Finance & PAO at BELLICUM PHARMACEUTICALS, INC · on record since Jun 11, 2019

Insider trading activity of Williams Rosemary Y.

Transactions on record: 14; since Jan 4, 2019

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 6, 2020

Figures computed from official regulatory filings — .

Companies where Williams Rosemary Y. has traded

BELLICUM PHARMACEUTICALS, INC14 tx · $3.7K · Jan 6, 2020

Track record of Williams Rosemary Y.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Williams Rosemary Y.

Co-insiders of Williams Rosemary Y.

Baker Bros. Advisors (GP) LLCBELLICUM PHARMACEUTICALS, INC
BAKER BROS. ADVISORS LPBELLICUM PHARMACEUTICALS, INC
BAKER FELIXBELLICUM PHARMACEUTICALS, INC
BAKER JULIANBELLICUM PHARMACEUTICALS, INC
BROWN JAMES FBELLICUM PHARMACEUTICALS, INC
Daly James MBELLICUM PHARMACEUTICALS, INC
DAVIS STEPHENBELLICUM PHARMACEUTICALS, INC
Fair Richard A.BELLICUM PHARMACEUTICALS, INC
Farrell Thomas J.BELLICUM PHARMACEUTICALS, INC
Foster Aaron E.BELLICUM PHARMACEUTICALS, INC
Grass Charles S.BELLICUM PHARMACEUTICALS, INC
Grossman WilliamBELLICUM PHARMACEUTICALS, INC
HARRIGAN EDMUNDBELLICUM PHARMACEUTICALS, INC
Hoang Peter L.BELLICUM PHARMACEUTICALS, INC
Huber Reid MBELLICUM PHARMACEUTICALS, INC
Klimovsky Judith VBELLICUM PHARMACEUTICALS, INC
McGuyer Frank B.BELLICUM PHARMACEUTICALS, INC
McGuyer Investments Ltd.BELLICUM PHARMACEUTICALS, INC
Mokari AtabakBELLICUM PHARMACEUTICALS, INC
Moseley AnnemarieBELLICUM PHARMACEUTICALS, INC
Moseley KenBELLICUM PHARMACEUTICALS, INC
Musso Alan ABELLICUM PHARMACEUTICALS, INC
Naeve Gregory S.BELLICUM PHARMACEUTICALS, INC
Remeditex Ventures LLCBELLICUM PHARMACEUTICALS, INC
Scripture CharityBELLICUM PHARMACEUTICALS, INC
Senesac JosephBELLICUM PHARMACEUTICALS, INC
Slawin Kevin M.BELLICUM PHARMACEUTICALS, INC
Smith Alan K.BELLICUM PHARMACEUTICALS, INC
Spencer David M.BELLICUM PHARMACEUTICALS, INC
Stonehouse Jon PBELLICUM PHARMACEUTICALS, INC
Strauss David EricBELLICUM PHARMACEUTICALS, INC
Ward ShaneBELLICUM PHARMACEUTICALS, INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	Exercise	1,282	—	n/a (No price was disclosed in the filing)	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	Other	-295	1.40 USD	$413	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	ExerciseD (derivative)	-1,282	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	ExerciseD (derivative)	-781	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	Exercise	781	—	n/a (No price was disclosed in the filing)	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	Other	-483	1.51 USD	$729.3	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jun 11, 2019	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Feb 5, 2019	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	ExerciseD (derivative)	-1,281	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	Exercise	1,281	—	n/a (No price was disclosed in the filing)	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	ExerciseD (derivative)	-782	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	Other	-483	3.33 USD	$1.6K	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	Other	-295	3.20 USD	$944	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	Exercise	782	—	n/a (No price was disclosed in the filing)	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	Exercise	1,282	—	n/a (No price was disclosed in the filing)	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	Other	-295	1.40 USD	$413	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	ExerciseD (derivative)	-1,282	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	ExerciseD (derivative)	-781	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	Exercise	781	—	n/a (No price was disclosed in the filing)	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 6, 2020	Other	-483	1.51 USD	$729.3	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jun 11, 2019	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Feb 5, 2019	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	ExerciseD (derivative)	-1,281	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	Exercise	1,281	—	n/a (No price was disclosed in the filing)	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	ExerciseD (derivative)	-782	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	Other	-483	3.33 USD	$1.6K	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	Other	-295	3.20 USD	$944	SEC
BELLICUM PHARMACEUTICALS, INCListing unverified	Jan 4, 2019	Exercise	782	—	n/a (No price was disclosed in the filing)	SEC